Showing 1–50 of 275 results

2020 FDA Approvals Ado-trastuzumab-emtansine
+
 Quick View

anti-human

Ado-trastuzumab emtansine Biosimilar – Research Grade [ICH4014]

$1,144.00 – $7,500.00
2020 FDA Approvals Aflibercept
+
 Quick View

anti-human

Aflibercept Biosimilar – Research Grade [ICH4015]

$600.00 – $5,000.00
Western Blot of Adalimumab Biosimilar ICH40012020 FDA Approvals Adalimumab
+
 Quick View

anti-human

Adalimumab Biosimilar – Research Grade [ICH4001]

$300.00 – $5,000.00
+
 Quick View

anti-human

Blinatumomab Biosimilar – Research Grade [ICH5025]

$300.00 – $4,000.00
Western Blot of Atezolizumab Biosimilar ICH4018
+
 Quick View

anti-human

Atezolizumab Biosimilar – Research Grade [ICH4018]

$718.00 – $5,000.00
2020 FDA Approvals for Trastuzumab
+
 Quick View

anti-human

Trastuzumab Biosimilar – Research Grade [ICH4013]

$718.00 – $5,000.00
+
 Quick View

anti-human

Theralizumab Biosimilar – Research Grade [ICH5023]

$300.00 – $5,000.00
Western Blot of Pembrolizumab Biosimilar ICH40292020 FDA Approvals for Pembrolizumab
+
 Quick View

anti-human

Pembrolizumab Biosimilar – Research Grade [ICH4029]

$718.00 – $5,000.00
2020 FDA Approvals for Rituximab
+
 Quick View

anti-human

Rituximab Biosimilar – Research Grade [ICH4011]

$718.00 – $5,000.00
2020 FDA Approvals for Ranibizumab
+
 Quick View

anti-human

Ranibizumab Biosimilar – Research Grade [ICH4031]

$718.00 – $4,161.00
2020 FDA Approvals Ipilimumab
+
 Quick View

anti-human

Ipilimumab Biosimilar – Research Grade [ICH4025]

$718.00 – $5,000.00
2020 FDA Approvals for Alemtuzumab
+
 Quick View

anti-human

Alemtuzumab Biosimilar – Research Grade [ICH4002]

$718.00 – $5,000.00
Natalizumab biosimilar
+
 Quick View

anti-human

Natalizumab Biosimilar – Research Grade [ICH4037]

$300.00 – $5,000.00
+
 Quick View

anti-human

Etanercept Biosimilar – Research Grade [ICH4022]

$718.00 – $5,000.00
2020 FDA Approvals for Pertuzumab
+
 Quick View

anti-human

Pertuzumab Biosimilar – Research Grade [ICH4030]

$718.00 – $5,000.00
+
 Quick View

Antibodies

Guselkumab Biosimilar – Research Grade [ICH5064]

$300.00 – $5,000.00
+
 Quick View

Antibodies

Tinurilimab Biosimilar – Research Grade [ICH5042]

$300.00 – $5,000.00
+
 Quick View

anti-human

Monalizumab Biosimilar – Research Grade [ICH5017]

$300.00 – $5,000.00
2020 FDA Approvals for Ustekinumab
+
 Quick View

anti-human

Ustekinumab Biosimilar – Research Grade [ICH4034]

$718.00 – $5,000.00
2020 FDA Approvals for Secukinumab
+
 Quick View

anti-human

Secukinumab Biosimilar – Research Grade [ICH4033]

$300.00 – $5,000.00
+
 Quick View

anti-human

Panitumumab Biosimilar – Research Grade [ICH4028]

$718.00 – $5,000.00
2020 FDA Approvals Eculizumab
+
 Quick View

anti-human

Eculizumab Biosimilar – Research Grade [ICH4005]

$300.00 – $5,000.00
2020 FDA Approvals Denosumab
+
 Quick View

anti-human

Denosumab Biosimilar – Research Grade [ICH4019]

$718.00 – $5,000.00
2020 FDA Approvals Bevacizumab
+
 Quick View

anti-human

Bevacizumab Biosimilar – Research Grade [ICH4003]

$718.00 – $5,000.00
+
 Quick View

anti-human

Urelumab Biosimilar – Research Grade [ICH5015]

$300.00 – $5,000.00
2020 FDA Approvals for Ofatumumab
+
 Quick View

anti-human

Ofatumumab Biosimilar – Research Grade [ICH4027]

$718.00 – $5,000.00
2020 FDA Approvals for Nivolumab
+
 Quick View

anti-human

Nivolumab Biosimilar – Research Grade [ICH4009]

$718.00 – $5,000.00
2020 FDA Approvals Cetuximab
+
 Quick View

anti-human

Cetuximab Biosimilar – Research Grade [ICH4004]

$718.00 – $5,000.00
Western Blot of Avelumab Biosimilar ICH40172020 FDA Approvals Avelumab
+
 Quick View

anti-human

Avelumab Biosimilar – Research Grade [ICH4017]

$718.00 – $5,000.00
+
 Quick View

Antibodies

Parsatuzumab Biosimilar – Research Grade [ICH5175]

$300.00 – $5,000.00
+
 Quick View

Antibodies

Relatlimab Biosimilar – Research Grade [ICH5117]

$300.00 – $5,000.00
+
 Quick View

Antibodies

Canakinumab Biosimilar – Research Grade [ICH5115]

$300.00 – $5,000.00
Western Blot of Infliximab Biosimilar ICH40062020 FDA Approvals Infliximab
+
 Quick View

anti-human

Infliximab Biosimilar – Research Grade [ICH4006]

$300.00 – $5,000.00
+
 Quick View

Antibodies

Tiragolumab Biosimilar – Research Grade [ICH5078]

$300.00 – $5,000.00
+
 Quick View

Antibodies

Sacituzumab Biosimilar – Research Grade [ICH5076]

$300.00 – $5,000.00
+
 Quick View

Antibodies

Abciximab Biosimilar – Research Grade [ICH5056]

$300.00 – $5,000.00
+
 Quick View

Antibodies

Cibisatamab Biosimilar – Research Grade [ICH5041]

$350.00 – $9,000.00
+
 Quick View

Antibodies

Magrolimab Biosimilar – Research Grade [ICH5036]

$300.00 – $5,000.00
+
 Quick View

anti-human

Mosunetuzumab Biosimilar – Research Grade [ICH5026]

$350.00 – $9,000.00
+
 Quick View

anti-human

Varlilumab Biosimilar – Research Grade [ICH5022]

$300.00 – $5,000.00
+
 Quick View

anti-human

Glofitamab Biosimilar – Research Grade [ICH5019]

$350.00 – $9,000.00
2020 FDA Approvals for Obinutuzumab
+
 Quick View

anti-human

Obinutuzumab Biosimilar – Research Grade [ICH4026]

$718.00 – $5,000.00
2020 FDA Approvals Alirocumab
+
 Quick View

anti-human

Alirocumab Biosimilar – Research Grade [ICH4016]

$718.00 – $15,000.00
+
 Quick View

Antibodies

Clenoliximab Biosimilar – Research Grade [ICH5193]

$300.00 – $5,000.00
+
 Quick View

Antibodies

Tremelimumab Biosimilar – Research Grade [ICH5184]

$300.00 – $5,000.00
+
 Quick View

anti-human

Mogamulizumab Biosimilar – Research Grade: HRP

$350.00
+
 Quick View

Antibodies

Envafolimab Biosimilar – Research Grade [ICH5177]

$300.00 – $5,000.00
+
 Quick View

Antibodies

Cemiplimab Biosimilar – Research Grade [ICH5161]

$300.00 – $5,000.00
+
 Quick View

Antibodies

Zilovertamab Biosimilar – Research Grade [ICH5158]

$300.00 – $5,000.00
+
 Quick View

Antibodies

Emibetuzumab Biosimilar – Research Grade [ICH5148]

$300.00 – $5,000.00